Semaglutide is best known for treating type 2 diabetes and supporting weight loss, but researchers have been studying another possible effect: whether it can reduce alcohol consumption. Here is what a recent clinical trial found, and how to interpret it.
What the study found
A randomized clinical trial published in JAMA Psychiatry in 2025 tested once-weekly semaglutide in adults with alcohol use disorder.[1] Participants who received semaglutide drank less alcohol than those who received placebo. The researchers linked the effect to semaglutide's action on the brain's reward and satiety pathways, the same systems involved in appetite.
Why this might happen
Semaglutide mimics GLP-1, a hormone that helps regulate appetite and blood sugar. GLP-1 receptors are also found in brain regions tied to reward and motivation, which is the leading explanation for why the medication might blunt cravings for alcohol as well as food. You can read more about how GLP-1 works.
What this does and does not mean
These are early, encouraging findings, but important limits apply. Semaglutide is not FDA-approved to treat alcohol use disorder, and the research is still developing. It should not be viewed as an approved or standard treatment for drinking, and IVUSE+ does not prescribe it for that purpose. Anyone concerned about their alcohol use should speak with a qualified healthcare or addiction professional about evidence-based options.
The bigger picture
This line of research is part of a broader effort to understand the many effects of GLP-1 medications beyond weight and blood sugar. As more data emerge, the role of these medications in other conditions will become clearer.
References
- Hendershot CS, Bremmer MP, Paladino MB, et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025;82(4):395-405.
This article is for general education and is not medical advice. Semaglutide is not approved for the treatment of alcohol use disorder. Compounded medications are not FDA-approved. Talk with a licensed clinician about appropriate treatment.
